trial
as of 2026-07-01Shared Decision Making for Schizophrenia
NCTId NCT00220870
at a glance
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
—
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2003-01
Primary completion
—
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Drugs
Indications
Sponsors
Technical University of MunichLead Sponsor
Investigators
1
Werner Kissling, MDStudy Chair
Sites
1 total
München, Germany
Facts & assertions
2 sourced
Phase
NA
Status
COMPLETED
relationships
The graph out of here
drug
drug
lead_sponsor
indication
investigator
person